Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Goldilocks Therapeutics, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Goldilocks Therapeutics, Inc.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: P8FKK278MDU8

Founded: —Source: [GOV]
Headquarters: Bedford, New YorkSource: [GOV]
Country: United StatesSource: [GOV]
Headcount: 1Source: [GOV]
Stage

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Goldilocks Therapeutics, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $305,844 in 2021. These are non-dilutive federal research grants, not equity financing. The company is based in Bedford, New York.

Funding rounds

1 rounds

1 round · latest SBIR Phase I award (HHS), Sep 2021

Investors

No investors recorded yet for Goldilocks Therapeutics, Inc..

Add an investor

People

Leadership

CHINTAN H KAPADIAPrincipal investigatorSince 2021Source: [GOV]

Acquisitions

Goldilocks Therapeutics, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Goldilocks Therapeutics, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare